DNA content was determined by flow cytometry in a series of 51 paired fresh tissue samples of primary colorectal carcinomas and the respective non-neoplastic adjacent mucosa in order to assess the relationship between DNA ploidy and the most commonly used prognostic factors. Aneuploidy was observed in 70.6% of the tumors and more than one aneuploid peak was present in 3.9%. Aneuploid tumor frequency was higher in left (93.3%) and right colon (64.7%) cancers than in rectal carcinomas (60.0%), and multiple aneuploid clones were detected more frequently in men than in women and in patients with advanced disease (Dukes stage D). Non-neoplastic mucosa adjacent to aneuploid tumors showed aneuploidy in 4 out of 51 samples (7.8%). The mucosa adjacent to diploid cancers had only diploid characteristics. Polidy did not correlate with histological abnormalities.
These findings suggest that DNA content as determined by flow cytometry needs further study with adequate follow-up to evaluate possible correlations with relapse-free and overall survival. Furthermore the aneuploidy of non-neoplastic mucosa provides evidence for a field defect in mucosa adjacent to colorectal cancer and supports the concept that this alteration may be of influence on carcinogenesis.
JassJ.R.Pathological staging.New methods and practical applications. Cancer Surveys1989; 8: 7–26.
2.
DukesC.The classification of cancer of the rectum.J Pathol1932; 35: 323–32.
3.
SteinbergS., BarkinJ., KaplanR., StableinD.Prognostic indicators of colon tumors: The Gastrointestinal Tumor Study Group experience.Cancer1986; 57: 1866–70.
4.
GriffinM., BergstralhE., CoffeyR., BeartR., MeltonLIIIPredictors of survival after curative resection of carcinoma of the colon and rectum.Cancer1987; 60: 2318–24.
5.
KokalW., SheibaniK., TerzJ., HaradaJ.R.Tumor DNA content in the prognosis of colorectal carcinoma.J Am Med Ass1986; 255: 3123–7.
6.
QuirkeP., DixonM.F., ClaydenA.D.Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas.J Pathol1987; 151: 285–91.
7.
RemvikosY., MulerisM., VielhP., SalmonA.C., DutrillauxB.DNA content and genetic evolution of human colorectal adenocarcinoma: a study by flow cytometry and cytogenetic analysis.Int J Cancer1988; 42: 539–43.
8.
JonesD.J., MooreM., SchofieldP.F.Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study.Br J Surg1988; 75: 28–33.
9.
FisherE.R., SideritisR.H., SassR., FisherB.Value of assessment of ploidy in rectal cancers.Arch Pathol Lab Med1989; 113: 525–8.
10.
ArmitageN.C., BallantyneK.C., EvansD.F., ClarkeP., SheffieldJ., HardcastleJ.D.The influence of tumor-cell DNA content on survival in colorectal cancer: a detailed analysis.Br J Cancer1990; 62: 852–6.
11.
KouriM., PyrhonenS., MecklinJ.P.The prognostic value of DNA ploidy in colorectal carcinoma: a prospective study.Br J Cancer1990; 62: 976–81.
12.
GiarettiW., DanovaM., GeidoE.Flow cytometric DNA index in the prognosis of colorectal cancer.Cancer1991; 67: 1921–7.
13.
RewD.A., WilsonG.D., TaylorI., WeaverP.C.Proliferation characteristics of human colorectal carcinomas measured in vivo.Br J Surg1991; 78: 60–6.
14.
CostaA., FarandaA., ScalmatiA.Autoradiographic and flow-cytometric assessment of cell proliferation in primary colorectal cancer: relationship to DNA ploidy and clinico-pathological features.Int J Cancer1992; 50: 719–23.
15.
JassJ.R., MukawaK., GohH.S., LoveS.B., CapellaroD.Clinical importance of DNA content in rectal cancer measured by flow cytometry.J Clin Pathol1989; 42: 254–9.
16.
JassJ.R., AtkinW.S., CuzickJ.The grading of rectal cancer: Historical perspectives and multivariate analysis of 447 cases.Histopathology1986; 10: 437–59.
17.
WiggersT., ArendsJ.W., SchutteB., VolovicsL., BosmanF.T.A multivariate analysis of pathological prognostic indicators in large-howel cancer.Cancer1988; 61: 386–95.
18.
DressierL.G., BartowS.A.DNA flow cytometry in solid tumors: practical aspects and clinical application.Semin Diagnost Pathol1989; 6: 55–82.
19.
DexterD.L., SpremulliE.N., FligielZ.Heterogeneity of cancer cells from a single human colon carcinoma.Am J Med1981; 71: 949–56.
20.
WerstoR.P., LiblitR.L., DeitchD., KossL.G.Variability in DNA measurements in multiple tumor samples of human colonic carcinoma.Cancer1991; 67: 106–15.
21.
FilipeM.I., BranfootA.C.Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma.Cancer1974; 34: 282–90.
22.
DawsonP.A., FilipeM.I.An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon.Cancer1976; 37: 2388–98.
23.
SaffosR.O., RhatiganR.M.Benign (non-polypoid) mucosal changes adjacent to carcinomas of the colon.A light microscopic study of 20 cases. Human Pathology1977; 8: 441–9.
24.
ShamsuddinA.K.M., WeissL., PhelpsP.C., TrumpB.F.Colon epithelium: IV.Human colon carcinogenesis: Changes in carcinoma of the colon. J Natl Cancer Inst1981; 66: 413–6.
25.
MonteroC., SeguraD.I.Retrospective histochemical study of mucosubstances in adenocarcinomas of the gastrointestinal tract.Histopathology1980; 4: 281–91.
26.
MorsonB.C., SobinL.H.Histological typing of intestinal tumors. In: International Histological Classification of Tumors.Geneva: WHO1976; 14.
27.
HolyokeE.D., LokichJ., WrightH.Adjuvant therapy for adenocarcinoma of the colon following clinically curative resection. In: Proceedings of the Gastrointestinal Tumor Study Group, National Cancer Institute.Bethesda, MD: NIH, 1975.
28.
Del BinoG., SilvestriniR., ZucconiM.R.DNA ploidy of human breast cancer.Ann Cell Pathol1989; 1: 215–23.
29.
LandisR.Y., HeymanE.R., KockG.G.Average partial association in three-way contingency tables.A review and discussion of alternative tests. Int Statistical Review1978; 46: 237–54.
30.
ScottN., CrossD., PlumbM.I., DixonM.F., QuirkeP.An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer.Br J Cancer1992; 65: 8–10.
31.
NgoiS.S., Staiano-CoicoL., GodwinT.A., WongR.J., DeCosseJ.J.Abnormal DNA ploidy and proliferative patterns in superficial colonic epithelium adjacent to colorectal cancer.Cancer1990; 66: 953–9.
32.
EnbladP., GlimeliusB., BengtssonA., PotenJ., PahlmanL.DNA content in carcinoma of the rectum and rectosigmoid.Acta Pathol Microbiol Immunol Scand1985; (Sect A) 93: 227–84.
33.
LofbergR., TribukaitB., OstA., BrostromO., ReichardH.Flow cytometric DNA analysis in longstanding ulcerative colitis.A method of prediction of dysplasia and carcinoma development? Gut1987; 28: 1100–6.
34.
MelvilleD.M., JassJ.R., ShepherdN.A.Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis.Observer variation and correlations. Gastroenterology1988; 9: 668–75.
35.
McHughJ.B.D., AhnenD.J.Aneuploidy as a marker of premalignant mucosa in patients with chronic ulcerative colitis (Abstr).Gastroenterology1989; 96(5): 334.
36.
PorschenR., RobinU., SchumacherA., SchauseilS., HengelsK.J., BorchardF.Detection of aneuploidy by flow cytometry reflects the epidemiological difference in colorectal cancer risk between Crohn's disease and ulcerative colitis (Abstr).Gastroenterology1989; 96(5): 396.
37.
DeanP.A., VernavaA.M.Flow cytometric analysis of DNA content in colorectal carcinoma.Dis Colon Rectum1992; 35: 95–102.
38.
Ponz De LeonM., RoncucciL., Di DonatoP.Pattern of epithelial-cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer in the large bowel.Cancer Res1988; 48: 4121–4.
39.
Ponz De LeonM., CostaA., LanzaG.Reliability of (3H) thymidine-labeling index: cell proliferation of colorectal carcinoma in three different centers.Mod Pathol1991; 4: 627–31.
40.
SilvestriniR., CostaA., GennariL., DociR., BombardieriE., BombelliL.Cell kinetics of hepatic metastases as a prognostic marker in patients with advanced colorectal carcinoma.Hepat Portobil Surg1990; 2: 135–44.
